Evidence map›Paper›PMID 24002637›Full record

ArticlePhysics in medicine and biology2013

Relationship between cavitation and loss of echogenicity from ultrasound contrast agents.

Kirthi Radhakrishnan, Kenneth B Bader, Kevin J Haworth, Jonathan A Kopechek, Jason L Raymond, Shao-Ling Huang, David D McPherson, Christy K Holland

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Assessment of Cavitation From DEFINITY and DEFINITY RT.Ultrasound in medicine & biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Quantitative Frequency-Domain Passive Cavitation Imaging.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kirthi RadhakrishnanBiomedical Engineering Program, University of Cincinnati, Cincinnati, OH, USA. radhakki@mail.uc.edu
Kenneth B Bader
Kevin J Haworth
Jonathan A Kopechek
Jason L Raymond
Shao-Ling Huang
David D McPherson
Christy K Holland
University of Cincinnati · USThe University of Texas Health Science Center at Houston · US

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
Ultrasound-Assisted Thrombolysis for Stroke TherapyR01NS047603 · NINDS · UNIVERSITY OF CINCINNATI · PI HOLLAND, CHRISTY K. · 2004 to 2018
$7.5M
Echogenic Targeted Liposomes:Transfection/Drug DeliveryR01HL074002 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2004 to 2013
$5.3M
TARGETED LIPOSOMES FOR ACOUSTIC CARDIOVASCULAR IMAGINGR01HL059586 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 1998 to 2012
$3.2M
Passive Cavitation Image-Guided Ultrasound-Mediated Drug Delivery for Atheroma ThF32HL104916 · NHLBI · UNIVERSITY OF CINCINNATI · PI HAWORTH, KEVIN JOSEPH · 2010 to 2011
$103k
NCATS NIH HHS 8 UL1 TR000077-04NCATS NIH HHS UL1 TR000077NHLBI NIH HHS F32 HL104916NHLBI NIH HHS F32HL104916NHLBI NIH HHS R01 HL059586NHLBI NIH HHS R01HL059586NHLBI NIH HHS R01 HL074002NHLBI NIH HHS R01HL074002NINDS NIH HHS R01 NS047603
6 · The paper itself

Abstract

Ultrasound contrast agents (UCAs) have the potential to nucleate cavitation and promote both beneficial and deleterious bioeffects in vivo. Previous studies have elucidated the pulse-duration-dependent pressure amplitude threshold for rapid loss of echogenicity due to UCA fragmentation. Previous studies have demonstrated that UCA fragmentation was concomitant with inertial cavitation. The purpose of this study was to evaluate the relationship between stable and inertial cavitation thresholds and loss of echogenicity of UCAs as a function of pulse duration. Determining the relationship between cavitation thresholds and loss of echogenicity of UCAs would enable monitoring of cavitation based upon the onscreen echogenicity in clinical applications. Two lipid-shelled UCAs, echogenic liposomes (ELIP) and Definity®, were insonified by a clinical ultrasound scanner in duplex spectral Doppler mode at four pulse durations ('sample volumes') in both a static system and a flow system. Cavitation emissions from the UCAs insonified by Doppler pulses were recorded using a passive cavitation detection system and stable and inertial cavitation thresholds ascertained. Loss of echogenicity from ELIP and Definity® was assessed within regions of interest on B-mode images. A numerical model based on UCA rupture predicted the functional form of the loss of echogenicity from ELIP and Definity®. Stable and inertial cavitation thresholds were found to have a weak dependence on pulse duration. Stable cavitation thresholds were lower than inertial cavitation thresholds. The power of cavitation emissions was an exponential function of the loss of echogenicity over the investigated range of acoustic pressures. Both ELIP and Definity® lost more than 80% echogenicity before the onset of stable or inertial cavitation. Once this level of echogenicity loss occurred, both stable and inertial cavitation were detected in the physiologic flow phantom. These results imply that stable and inertial cavitation are necessary in order to trigger complete loss of echogenicity acoustically from UCAs and this finding can be used when planning diagnostic and therapeutic applications.

Indexed as

UltrasonicsAcousticsAlgorithmsContrast MediaFluorocarbonsHumansLipidsLiposomesMicrobubblesPhantoms, ImagingPressureSoftwareSonicationUltrasonography, DopplerContrast MediaFluorocarbonsLipidsLiposomesperflutren

Identifiers

PMID24002637
PMCPMC4170692
OpenAlexW2072710643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.